FDA Import Refusal 799-2348979-1/21/1 — Janssen Inc.
The FDA refused shipment 799-2348979-1/21/1 from Janssen Inc. (Canada) on Sep 9, 2019. The refused product falls under Drugs and Biologics — CANAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 9, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY69 CANAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75